BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6294791)

  • 1. Comparative susceptibility of Yersinia enterocolitica, Eikenella corrodens, and penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to beta-lactam and alternative antimicrobial agents.
    Goldstein EJ; Cherubin CE; Corrado ML; Sierra MF
    Rev Infect Dis; 1982; 4 Suppl():S406-10. PubMed ID: 6294791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Eikenella corrodens to newer beta-lactam antibiotics.
    Goldstein EJ; Gombert ME; Agyare EO
    Antimicrob Agents Chemother; 1980 Nov; 18(5):832-3. PubMed ID: 7004350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Eikenella corrodens to penicillin, apalcillin, and twelve new cephalosporins.
    Goldstein EJ; Citron DM
    Antimicrob Agents Chemother; 1984 Dec; 26(6):947-8. PubMed ID: 6395802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Eikenella corrodens to antimicrobial agents.
    Sofianou D; Kolokotronis A
    J Chemother; 1990 Jun; 2(3):156-8. PubMed ID: 2199625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis.
    Tweardy DJ; Jacobs MR; Speck WT
    J Antimicrob Chemother; 1983 Aug; 12(2):133-9. PubMed ID: 6555189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Eikenella corrodens to ten cephalosporins.
    Goldstein EJ; Sutter VL; Finegold SM
    Antimicrob Agents Chemother; 1978 Oct; 14(4):639-41. PubMed ID: 363054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae.
    Pikis A; Donkersloot JA; Akram S; Keith JM; Campos JM; Rodriguez WJ
    J Antimicrob Chemother; 1997 Jul; 40(1):105-8. PubMed ID: 9249211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to new beta-lactams of enterobacterial extended-spectrum beta-lactamase (ESBL) producers and penicillin-resistant Streptococcus pneumoniae in Mexico.
    Silva J; Aguilar C; Estrada MA; Echániz G; Carnalla N; Soto A; López-Antuñano FJ
    J Chemother; 1998 Apr; 10(2):102-7. PubMed ID: 9603634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of Yersinia kristensenii strains to beta-lactam antibiotics.
    Bejar V; Calvo C; Ramos Cormenzana A
    Ann Inst Pasteur Microbiol (1985); 1986; 137A(2):169-77. PubMed ID: 3501272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
    Pankuch GA; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli.
    Dabernat HJ; Delmas C
    Rev Infect Dis; 1982; 4 Suppl():S401-5. PubMed ID: 6294790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial resistance of Streptococcus pneumoniae, 2003-2009].
    Năstase E; Dorneanu O; Dorobăţ C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):536-41. PubMed ID: 21870753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of Eikenella corrodens from pulmonary infections.
    Goldstein EJ; Kirby BD; Finegold SM
    Am Rev Respir Dis; 1979 Jan; 119(1):55-8. PubMed ID: 369416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Gomez-Lus R; Navarro C; Egido P; Aspiroz C; Goñi P; Vergara Y; Garcia C; Duran E; Castillo J; Rubio MC
    J Chemother; 2000 Feb; 12(1):17-21. PubMed ID: 10768511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of pneumococci to 14 beta-lactam agents: comparison of strains resistant, intermediate-resistant, and susceptible to penicillin.
    Ward JI; Moellering RC
    Antimicrob Agents Chemother; 1981 Aug; 20(2):204-7. PubMed ID: 6912777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study.
    Thornsberry C; Burton PH; Vanderhoof BH
    Diagn Microbiol Infect Dis; 1996 Jun; 25(2):89-95. PubMed ID: 8882895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of Bacteroides corrodens and Eikenella corrodens to ten chemotherapeutic agents.
    Robinson JV; James AL
    Antimicrob Agents Chemother; 1974 Nov; 6(5):543-6. PubMed ID: 15825302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the in-vitro activity of cefepime and other antimicrobial agents against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Yee YC; Thornsberry C; Brown SD; Bouchillon SK; Marler JK; Rich T
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():13-9. PubMed ID: 8150756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.